# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Isaac Newton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN011-SYN
- Date: 2026-10-22
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rupert Okonkwo-Fairbanks, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: Periodic preventive medicine visit, established patient, age 40 to 64, with voluntary advance care planning

## Chief complaint

Preventive health visit at 50. **S**

## History of present illness

Mr. Newton returns for his preventive visit at 50, two weeks after starting sertraline 50 mg and three and a half weeks after the laboratory was closed. His cold cleared within five days without antibiotics. He completed the health risk questionnaire beforehand. He has no side effects from sertraline now, has missed no doses, and has had two sessions of cognitive behavioral therapy. He sleeps about five hours, keeps a fixed rising time, and no longer dozes in his chair in the evening. He eats three small meals a day and has gained 0.5 kg. His mood is a little better; he has written to the friends he accused to apologize. He has had no thoughts of death or of harming himself or anyone else. He has never had colorectal cancer screening. **S**

| Element | Detail |
|---|---|
| Visit | Preventive health visit, age 50 |
| Active conditions | Major depression on sertraline and CBT; insomnia improving with CBT-I; raised urine mercury after removal from exposure |
| Medicines | Sertraline 50 mg; acetaminophen no longer needed |
| Screening history | No colorectal screening; HIV and hepatitis C tests negative in his forties |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair, improving |
| Psychosocial | Lives alone; repairing strained friendships; no financial worries |
| Behavioral | Never smoker; wine rarely (AUDIT-C 1); walks about 30 minutes most days; diet plain and irregular until recently |
| Occupational | Laboratory closed pending decontamination and a fume hood; teaching continues |
| Activities of daily living | Independent |
| Home safety | Smoke and carbon monoxide detectors in his rooms; no firearms |
| Sexual health | Not sexually active; no risk factors for sexually transmitted infection |
| Hearing and vision | Hears well; reading glasses; eye examination two years ago |
| Sleep | About five hours a night, improving with CBT-I |
| Pain | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight 64.3 kg, up 0.5 kg; energy improving; no fever since the cold |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Cold resolved; no gum bleeding, mouth ulcers, or excess salivation |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | Cough gone; no breathlessness |
| Gastrointestinal | Negative | No nausea, bleeding, or change in bowel habit |
| Genitourinary | Negative | No urinary symptoms; no frothy urine |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash |
| Neurological | Negative | No tremor, numbness, or tingling |
| Psychiatric | Positive | Mood a little better; PHQ-9 16; no thoughts of death or of harming himself or others |

11 systems reviewed. **S**

## Current medications

- Sertraline 50 mg oral tablet, one tablet by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 64.3 kg; BMI 22.2 kg/m². All vital signs are synthetic.

PHQ-9: 16; Total cholesterol: 176 mg/dL; HDL cholesterol: 61 mg/dL; LDL cholesterol: 98 mg/dL; Triglycerides: 86 mg/dL. All results are synthetic.

## Change since baseline

- PHQ-9: 20 at baseline, 16 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**
- Pneumococcal conjugate vaccine PCV20 **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin, better kept; BMI 22.2 |
| Mouth | Gums healthy; no stomatitis |
| Cardiovascular | Regular rhythm; no murmur; blood pressure 120/76 mmHg |
| Respiratory | Clear |
| Abdomen | Soft, non-tender; no masses |
| Neurological | No postural or intention tremor; handwriting steady |
| Psychiatric | Calmer; mood "a little less heavy"; no suspicious ideas expressed |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Preventive health visit completed**. Health risk assessment reviewed and a personalized prevention plan made. His main risks are the depressive episode and the recent occupational exposure, both under treatment; lipids are normal. **S**
   - Next preventive visit in one year.
2. **Major depressive disorder** (F32.2). PHQ-9 16, down from 20, two weeks into sertraline 50 mg; no side effects now and no missed doses; no suicidal thoughts or thoughts of harming others. **S**
   - Continue sertraline 50 mg and weekly CBT; depression review in one week as planned.
3. **Acute viral upper respiratory infection** (J06.9). Resolved within five days. **S**
   - No further action.

## Medication changes

- Stopped: Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for aches or fever, no more than 3 g a day **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | Given today |
| Pneumococcal conjugate vaccine | Completed today | PCV20 given today; recommended for all adults aged 50 and over |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| COVID-19 vaccine, this season | Due | He preferred not to have a fourth injection today and will have it at his pharmacy within the month |
| Tetanus booster | Up to date | Tdap six years ago |
| Hepatitis B vaccine | Up to date | Two-dose adult series completed seven years ago |
| Colorectal cancer screening | Ordered | Never screened; he chose a yearly fecal immunochemical test over colonoscopy; kit given today |
| Depression screening | Completed today | PHQ-9 16 while under treatment |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 176 mg/dL, HDL 61 mg/dL, LDL 98 mg/dL, triglycerides 86 mg/dL; blood pressure 120/76 mmHg; never smoker; low 10-year risk, so no statin |
| Diabetes screening | Not indicated | BMI 22.2 and no other risk factors; glucose 88 mg/dL at intake |
| HIV and hepatitis C screening | Up to date | One-time tests negative in his forties |
| Alcohol misuse screening | Completed today | AUDIT-C 1 |
| Prostate cancer screening | Not indicated | Shared decision about PSA screening is offered from 55; he has no family history known to him |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker |
| Hearing and vision | Up to date | No concerns; eye examination two years ago |

## Advance care planning

Voluntary advance care planning discussion of about 16 minutes, with his consent. He has never written a directive. He names a younger colleague and friend from his college as his health care agent and will complete the state form at his next visit. He would want full treatment for any illness he might recover from. He asked that his health information be shared only with his care team and his agent. **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices (2024), Centers for Disease Control and Prevention (MMWR)
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force

## Follow-up

- Depression and exposure review in one week as planned, with a repeat 24-hour urine mercury. Second zoster dose in two to six months. Fecal immunochemical test kit to be returned within two weeks. **S**
- Next scheduled visit 2026-10-29: three-week depression and exposure follow-up with a repeat 24-hour urine mercury. **S**
